UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025058
Receipt number R000028697
Scientific Title Changes of laryngeal airway patency in anesthetized children with supraglottic airway devices
Date of disclosure of the study information 2016/11/29
Last modified on 2018/10/01 10:22:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes of laryngeal airway patency in anesthetized children with supraglottic airway devices

Acronym

Laryngeal airway patency in anesthetized children with suplaglottic airway devices

Scientific Title

Changes of laryngeal airway patency in anesthetized children with supraglottic airway devices

Scientific Title:Acronym

Laryngeal airway patency in anesthetized children with suplaglottic airway devices

Region

Japan


Condition

Condition

anesthetized children with suplaglottic airway devices

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test an hypothesis that use of sugammadex for reversal of muscle paralysis changes laryngeal airway patency during emergence from general anesthesia in children with suplaglottic airway devices.

Basic objectives2

Others

Basic objectives -Others

To explore whether mechanical parameters such as respiratory sound and respiratory resistance reflect changes of laryngeal airway patency.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

vocal cord angle

Key secondary outcomes

respiratory mechanics parameters such as respiratory sound and respiratory resistance


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

6 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients who will be anesthetized for inguinal hernia surgery and cryptorchidism surgery
2)Patients whom supraglottic airway devices will be used for
3)Patients who is categorized as American Society of Anesthesia-Physical status 1-3
4)Patients whose weight is over 10 kg at the surgery time
5)Patients whose age is under 6 years old at the surgery time
6)No regard to sex
7)Patients whose parents are given informed
consent about this research

Key exclusion criteria

1)Patients who are at the risk of aspiration
2)Patients whose surgery will be laparoscopic
3)Patients who is under oxypathy
4)Patients who have coagulation abnormality
5)Patients whom supraglottic airway devices don't fit
6)Patients who are under tubal feeding
7)Patients who have the history of larynx disease
8)Patients who take anti-convulsion drugs
9)Patients who have the history of being intubated within one month
10)Patients who are thought to be inadequate by researchers

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Kitamura

Organization

Chiba University Hospital

Division name

Depatment of Anesthesiology

Zip code


Address

inohana1-8-1,Chuou ku ,Chiba City,Chiba Ken

TEL

043-222-7171

Email

yuji.kitamura@chiba-u.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shiroh Isono

Organization

Chiba Graduate School of Medicine

Division name

Anesthesiology

Zip code


Address

Inohana 1-8-1,Chuou ku,Chiba City,Chiba ken

TEL

043-222-7171

Homepage URL


Email

shirohisono@yahoo.co.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education,Culture,Sports,Science and Technology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 14 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 30 Day

Last follow-up date


Date of closure to data entry

2018 Year 07 Month 27 Day

Date trial data considered complete

2018 Year 09 Month 03 Day

Date analysis concluded



Other

Other related information

We will endoscopically observe and measure the vocal cord angle of the anesthetized children through a supraglottic airway device(SAD). Primary outcome measure is the change of the vocal cord angle before and after reversal of muscle paralysis by sugammadex and the secondary outcome is characteristics of respiratory sounds and other respiratory mechanics parameters such as tidal volume.

Study protocol
1) A written informed consent is obtained from each of the parent of the child who is scheduled to have a minor surgery in our hospital. Premedication will be used if needed.
2) At operation room, the child will be anesthetized by inhalational anesthetics such as sevoflurane and nitrous oxide and a venous line is secured after appropriate cardiorespiratory monitor such as pulse oximetry is attached to the child. After placement of a SAD, general anesthesia is maintained by appropriate dose of sevoflurane, fentanyl, remifentanil and rocuronium. Mechanical ventilation will be started for maintaining optimal oxygenation and ventilation during the surgery while measuring the respiratory parameters. An endoscope will be inserted through the SAD to measure the vocal cord angle. The respiratory parameters and endoscopic images were displayed on the screen and stored in a computer for later analysis. The measurement will be ceased when the SAD is removed after completion of the surgery.


Management information

Registered date

2016 Year 11 Month 29 Day

Last modified on

2018 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028697


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name